Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
AEOLUS PHARMACEUTICALS, INC. (AOLS) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/10/2011 BW Aeolus to Present at the ROTH Capital Partners 23rd Annual OC Growth Stock Conference
02/18/2011 BW Company Profile for Aeolus Pharmaceuticals, Inc.
02/15/2011 BW Aeolus Awarded Contract Fully Valued at $118 Million from BARDA to Develop Treatment for Lung Acute Radiation Syndrome
02/15/2011 BW Aeolus Pharmaceuticals Announces Appointment of Russell L. Skibsted as Senior Vice President and Chief Financial Officer
11/15/2010 BW Aeolus to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
11/02/2010 BW Aeolus Pharmaceuticals' AEOL 10150 Promotes Survival in Non-Human Primates Exposed to Lethal Doses of Radiation
11/01/2010 BW Aeolus Pharmaceuticals to Present at Oppenheimer 21st Annual Healthcare Conference
08/12/2010 BW Aeolus Pharmaceuticals Completes $1.0 Million Financing and Receives an Option to Raise Additional $1.0 Million
06/29/2010 BW Aeolus Pharmaceuticals' AEOL 10150 Provides Significant Protection of Skin in Pre-Clinical Studies of Mustard Gas Exposure
05/17/2010 BW Aeolus Pharmaceuticals Announces Second Quarter Fiscal Year 2010 Financial Results
04/12/2010 BW Aeolus Pharmaceuticals Announces the Initiation of a Second Study of AEOL 10150 as a Medical Countermeasure for GI Acute Radiation Syndrome Funded by the National Institutes of Health??s National Institute for Allergy and Infectious Diseases
02/19/2010 BW Aeolus Pharmaceuticals Announces First Quarter Fiscal Year 2010 Financial Results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy